PLSE
Pulse Biosciences·NASDAQ
--
--(--)
--
--(--)
PLSE Filings
Filing Date
Form Description
Form Type
2026-03-27
Form 8-K - Current report
Key Events
2026-03-27 · Key Events
Form 8-K - Current report
2026-03-17
Form 8-K - Current report
Key Events
2026-03-17 · Key Events
Form 8-K - Current report
2026-03-12
Form 8-K - Current report
Key Events
2026-03-12 · Key Events
Form 8-K - Current report
2026-03-09
Form 8-K - Current report
Key Events
2026-03-09 · Key Events
Form 8-K - Current report
2026-03-03
Form 8-K - Current report
Key Events
2026-03-03 · Key Events
Form 8-K - Current report
2026-03-02
Form 8-K/A - Current report: [Amend]
Key Events
2026-03-02 · Key Events
Form 8-K/A - Current report: [Amend]
2026-03-02
Form EFFECT - Notice of Effectiveness
2026-03-02 ·
Form EFFECT - Notice of Effectiveness
2026-02-27
Form 8-K - Current report
Key Events
2026-02-27 · Key Events
Form 8-K - Current report
2026-02-23
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-23 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-02-19
Pulse Biosciences, Inc. (PLSE) Q4 2025 Earnings Call Transcript
Earnings Call
2026-02-19 · Earnings Call
Pulse Biosciences, Inc. (PLSE) Q4 2025 Earnings Call Transcript
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
